These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Separation and purification of the hemagglutinins from Bordetella pertussis. Sato Y, Cowell JL, Sato H, Burstyn DG, Manclark CR. Infect Immun; 1983 Jul 01; 41(1):313-20. PubMed ID: 6305841 [Abstract] [Full Text] [Related]
12. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R, Lønnes T, Møgster B, Berdal BP. Dev Biol Stand; 1985 Jan 01; 61():353-65. PubMed ID: 2872124 [Abstract] [Full Text] [Related]
14. Crossed immunoelectrophoretic analysis of Bordetella pertussis antigens and of corresponding antibodies in human sera. Hertz JB, Hølby N, Andersen V, Baekgaard P. Acta Pathol Microbiol Scand B; 1976 Dec 01; 84B(6):386-94. PubMed ID: 187009 [Abstract] [Full Text] [Related]
15. Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s. Munoz J, Hestekin BM. J Bacteriol; 1966 Jun 01; 91(6):2175-9. PubMed ID: 4287581 [Abstract] [Full Text] [Related]
17. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques. Gupta RK, Saxena SN, Sharma SB, Ahuja S. Dev Biol Stand; 1991 Jun 01; 73():205-22. PubMed ID: 1778314 [Abstract] [Full Text] [Related]